In light of the coronavirus outbreak, many companies chose to - or had to - adapt their core activities. One of our customers, I-Stem, acted quickly right from the very start of the lockdown.

Their robotic platforms, originally dedicated to stem cell research, have been used to manage patient samples, taking part in the effort to increase the number of Covid-19 tests available to the public. 

Discngine and I-Stem teams have worked together designing an easy way to accelerate the analysis of PCR results via Assay, and producing reports fully compliant with HL7 Standards that are sent directly to hospitals.

Working on a similar project? We will be very glad to help you if you need assistance speeding up data analysis for your PCR kits (or other types of assays).
Reach out to Thomas Blarre from the Discngine Assay team to plan a 1-on-1 meeting.